Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.

All News

Sharma Oral Surgery Marks 25 Years of Service with New Partner and Renewed Commitment to Excellence
Healthcare & PharmaceuticalCompany Update

Sharma Oral Surgery Marks 25 Years of Service with New Partner and Renewed Commitment to Excellence

May 21, 2026 9:00 AM

Sharma Oral Surgery, an advanced oral surgery practice founded in 2001, proudly celebrates its 25th anniversary this year, marking a quarter century of exceptional service and relationships in Charlotte, North Carolina. Looking ahead, the company reaffirms its commitment to oral surgery excellence in the region, adding Dr. Rodrigo Sarmento, DMD, MD, to the team last year and increasing its capacity to provide trusted oral surgery services,...

Read more
HealthJoy's Benefits Operating System Drives 18% Savings on Medical Procedures Through Intelligent Steerage
Healthcare & PharmaceuticalProduct Announcements

HealthJoy's Benefits Operating System Drives 18% Savings on Medical Procedures Through Intelligent Steerage

May 21, 2026 9:00 AM

HealthJoy, a benefits operating system for employers nationwide, today released a new actuarial cost savings report quantifying the impact of HealthJoy's AI-driven solution on medical spending among employers and their employees. Independently validated by Axene Health Partners (AHP), the study reveals that HealthJoy-guided care can drive down procedural healthcare costs by nearly 18% and even more in high-volume care categories such as...

Read more
UniDoc Reflects on Successes One Year After AMD Telemedicine Software Purchase
Healthcare & PharmaceuticalCompany Update

UniDoc Reflects on Successes One Year After AMD Telemedicine Software Purchase

May 21, 2026 7:30 AM

UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company") is pleased to provide a one-year integration update following its purchase of AGNES Connect software and related AMD Telemedicine assets. The Company has fully integrated the AMD software and related systems into UniDoc's ecosystem, retained more than 97% of AMD's active clients and added 59 new sites during the last year.Key Takeaways:AMD Telemedicine software and...

Read more
Grundium Acquires Visiopharm to Create Integrated Precision Pathology Platform
Healthcare & PharmaceuticalMergers and Acquisitions

Grundium Acquires Visiopharm to Create Integrated Precision Pathology Platform

May 21, 2026 7:30 AM

Grundium Oy, a leader in advanced digital scanning backed by US-based healthcare private equity firm EW Healthcare Partners, has today announced the acquisition of Visiopharm A/S, a leading AI-driven precision pathology software company. The acquisition is a significant step towards Grundium's strategy to build a broader digital and computational pathology platform.The combined business brings together complementary capabilities from Grundium's...

Read more
Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin
Healthcare & PharmaceuticalCompany Update

Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin

May 21, 2026 7:00 AM

Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications, is pleased to announce the approval of its generic Amoxicillin formulation for the Canadian market. This strategic expansion reinforces Sunshine Biopharma's commitment to providing affordable, high-quality antibiotics to patients across Canada.Amoxicillin, a widely prescribed penicillin-class...

Read more
Sapyen Launches Sperm Freezing Service for $1
Healthcare & PharmaceuticalProduct Announcements

Sapyen Launches Sperm Freezing Service for $1

May 21, 2026 1:30 AM

Global male fertility company Sapyen today launches sperm freezing for one dollar. The price covers the first full year of storage, and the next five years are available at a fraction of clinic pricing. Unlike traditional programs that freeze a sample immediately, Sapyen's model begins earlier. The program starts with an at-home semen analysis, followed by Reset90™, a ninety-day supplement and lifestyle protocol designed around the biological...

Read more
Infinx Expands Louisiana Presence with New Center of Excellence in New Orleans
Healthcare & PharmaceuticalCompany Update

Infinx Expands Louisiana Presence with New Center of Excellence in New Orleans

May 20, 2026 6:10 PM

Infinx, a company focused on helping healthcare organizations improve financial performance and operational efficiency, today announced the opening of a Center of Excellence in New Orleans, marking another milestone in the company's continued expansion across Louisiana.The New Orleans facility reflects Infinx's long-term commitment to its strategic partners in the region to build a stronger, more localized presence in markets where it serves...

Read more
Wellgistics Health Announces Reverse Stock Split
Healthcare & PharmaceuticalCompany Update

Wellgistics Health Announces Reverse Stock Split

May 20, 2026 6:00 PM

Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics" or the "Company"), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence (AI) platform EinsteinRx™ into its patented blockchain-enabled smart contracts platform PharmacyChain™, today announced that its board of directors approved the Company's 1-for-50 reverse stock split (the "Reverse Split") of the Company's common stock,...

Read more
Jaguar Health Reports First Quarter 2026 Financials
Healthcare & PharmaceuticalEarnings

Jaguar Health Reports First Quarter 2026 Financials

May 20, 2026 4:40 PM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today reported its consolidated first-quarter 2026 financial results.2026 FIRST QUARTER COMPANY FINANCIAL RESULTS:License and Grant Revenue: Effective January 12, 2026, Jaguar entered a U.S. licensing agreement with Woodward Specialty, LLC ("Woodward"), an affiliate of privately held Future Pak, LLC ("Future Pak"). Under the terms of the agreement, Future Pak is now the exclusive U.S....

Read more
Glidewell Selects 43 Dentists for 2026 Guiding Leaders Cohort
Healthcare & PharmaceuticalConferences

Glidewell Selects 43 Dentists for 2026 Guiding Leaders Cohort

May 20, 2026 12:00 PM

Glidewell, America's foremost dental laboratory and longtime provider of world-class continuing education solutions, has selected 43 dentists for the 2026 cohort of Guiding Leaders, the company's six-month leadership and business development program for practicing dentists.Now in its sixth year, Guiding Leaders addresses the business, communication, and leadership skills that clinical training does not cover. The selection committee reviewed...

Read more
Emerging Growth Research Releases Q1:26 Quarterly Update on SBC Medical Group; Upgrades to Buy Rating and Increases Price Target to $10.00
Healthcare & PharmaceuticalEarnings

Emerging Growth Research Releases Q1:26 Quarterly Update on SBC Medical Group; Upgrades to Buy Rating and Increases Price Target to $10.00

May 20, 2026 10:15 AM

Emerging Growth Research today announced the release of its Q1:26 Quarterly Update Report on SBC Medical Group Holdings, Inc. (NASDAQ:SBC), upgrading the Company to a Buy rating and increasing its 12-month price target to $10.00 from $9.00, representing significant potential upside from the Company's recent share price of $2.89 as of May 19, 2026.The Quarterly Update highlights SBC's expectation for a return to revenue growth in 2026 following...

Read more
CNS Pharmaceuticals CEO, Rami Levin, Participates in Virtual Investor CEO Connect Segment Highlighting Company's Recent Strategic Transformation Progress
Healthcare & PharmaceuticalCompany Update

CNS Pharmaceuticals CEO, Rami Levin, Participates in Virtual Investor CEO Connect Segment Highlighting Company's Recent Strategic Transformation Progress

May 20, 2026 9:02 AM

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biotechnology company focused on building a pipeline of innovative therapies addressing significant unmet medical needs, today announced that it participated in a Virtual Investor CEO Connect Segment.As part of the segment, Rami Levin, President and Chief Executive Officer of CNS Pharmaceuticals, highlighted the Company's recent $22.5 million financing, including its strategic...

Read more
Jaguar Health to Hold Investor Webcast May 26 Regarding Q1 2026 Financials & Corporate Updates; Jaguar CEO Lisa Conte Presenting May 28 at Lytham Partners Spring 2026 Investor Conference
Healthcare & PharmaceuticalConference Call

Jaguar Health to Hold Investor Webcast May 26 Regarding Q1 2026 Financials & Corporate Updates; Jaguar CEO Lisa Conte Presenting May 28 at Lytham Partners Spring 2026 Investor Conference

May 20, 2026 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the company will conduct an investor webcast on Tuesday, May 26, 2026 at 8:30 a.m. Eastern to review first-quarter 2026 financials and provide corporate updates, and that Lisa Conte, Jaguar's founder, president and CEO, will present virtually on Thursday, May 28, 2026 at 10 a.m. Eastern at the Lytham Partners Spring 2026 Investor Conference.Participation Instructions for Jaguar Health...

Read more
Aetna Better Health(R) of Louisiana Collaborates With Goodr To Launch Mobile Food Market and Chronic Care Program
Healthcare & PharmaceuticalEnvironmental, Social and Governance

Aetna Better Health(R) of Louisiana Collaborates With Goodr To Launch Mobile Food Market and Chronic Care Program

May 20, 2026 9:00 AM

Originally published on CVS Health Company NewsroomAetna Better Health® of Louisiana, a CVS Health® company (NYSE:CVS), today announced a new collaboration with Goodr, a hunger and food waste solutions company, to address food insecurity and support chronic disease management across Louisiana.One in six people face food insecurity in Louisiana. Through a $400,000 investment, Aetna will work with Goodr to bring a Food is Medicine Mobile Market...

Read more
TRNR Reports Q1 2026 Results, Driven By 279% Revenue Growth; Confirms 2026 Pro Forma Revenue Guidance of More Than $30m
Healthcare & PharmaceuticalEarnings

TRNR Reports Q1 2026 Results, Driven By 279% Revenue Growth; Confirms 2026 Pro Forma Revenue Guidance of More Than $30m

May 20, 2026 8:30 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, CLMBR, FORME and Ergatta brands, today announced financial results for its first quarter ended March 31, 2026.Q1 2026 Financial HighlightsQ1 2026 revenue was $5.1 million, a 279% increase compared to $1.4 million in Q1 2025. Reported revenue reflects 21 days of Ergatta consolidation following the March 11, 2026...

Read more
Telomir Pharmaceuticals Reports Peer-Reviewed Publication of Telomir-Zn Data Demonstrating Improved Survival and Multiple Endpoint Benefits in Wilson's Disease
Healthcare & PharmaceuticalCompany Update

Telomir Pharmaceuticals Reports Peer-Reviewed Publication of Telomir-Zn Data Demonstrating Improved Survival and Multiple Endpoint Benefits in Wilson's Disease

May 20, 2026 8:00 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a clinical-stage biotechnology company developing small-molecule therapeutics targeting epigenetic and metabolic drivers of cancer and age-related disease, today announced the peer-reviewed publication of preclinical data showing that Telomir-Zn produced dose-dependent survival improvement across multiple endpoints in a Wilson's disease model, supporting the biological...

Read more
Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures
Healthcare & PharmaceuticalCompany Update

Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures

May 20, 2026 7:45 AM

Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB:RVVTF)(CSE:RVV)(FRANKFURT:31R), a life sciences company focused on infectious diseases and medical countermeasures, today announced its strategic expansion plan for bucillamine across infectious disease, defence and biothreat-related applications.Revive believes bucillamine represents a differentiated strategic asset with potential relevance across multiple high-need areas, including...

Read more
Avel eCare Highlights Virtual Health as a Long Term Workforce Strategy for Rural Health Transformation
Healthcare & PharmaceuticalCompany Update

Avel eCare Highlights Virtual Health as a Long Term Workforce Strategy for Rural Health Transformation

May 20, 2026 7:18 AM

As healthcare organizations across the country continue facing workforce shortages, provider burnout, financial pressure, and increasing challenges recruiting clinicians to rural communities, healthcare leaders are searching for solutions that go beyond temporary staffing fixes and short term incentives.Avel eCare, the nation's leading Virtual Health System, is helping healthcare organizations reframe telemedicine not simply as a technology...

Read more
Zomedica's PulseVet System Repeats as Official Shock Wave of the United States Eventing Association
Healthcare & PharmaceuticalCompany Update

Zomedica's PulseVet System Repeats as Official Shock Wave of the United States Eventing Association

May 20, 2026 6:00 AM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic products for equine and companion animals, today announced the renewal of its sponsorship agreement with the United States Eventing Association (USEA). With this partnership, PulseVet is again named as the "Official Shock Wave of the USEA", reinforcing the ongoing commitment of Zomedica to support...

Read more
Onco-Innovations Reports Continued Advancement of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for ONC010 Development Program
Healthcare & PharmaceuticalCompany Update

Onco-Innovations Reports Continued Advancement of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for ONC010 Development Program

May 19, 2026 6:00 PM

Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce, further to its news release dated April 28, 2026, continued progress in the intermediate1 scale-up and process development activities for the A83 and B4 precursor components supporting the Company's lead oncology program, ONC010, a novel nanoparticle-formulated PNKP inhibitor currently advancing through IND-enabling...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?